Unique role of NADPH oxidase 5 in oxidative stress in human renal proximal tubule cells

Redox Biology

Volumn 2, Issue 1, 2014, Pages 570-579

  Yu, Peiying ^a   Han, Weixing ^b   Villar, Van Anthony M ^a   Yang, Yu ^a   Lu, Quansheng ^c   Lee, Hewang ^a   Li, Fengmin ^d   Quinn, Mark T ^e   Gildea, John J ^f   Felder, Robin A ^f   Jose, Pedro A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e MONTANA STATE UNIVERSITY   (United States)

^f UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Dopamine receptor; NOX5; Oxidative stress; ROS

Indexed keywords

DIPHENYLIODONIUM SALT; DOPAMINE 1 RECEPTOR; MEMBRANE ENZYME; MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 5; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; IONOMYCIN; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; CATION; ISOENZYME; MEMBRANE PROTEIN; NOX5 PROTEIN, HUMAN;

ADULT; APICAL MEMBRANE; ARTICLE; CELL STRESS; CONTROLLED STUDY; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; GENE; GENE EXPRESSION; GENE LOCATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; KIDNEY CELL; KIDNEY PROXIMAL TUBULE; NOX5 GENE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ENZYME ANALYSIS; ENZYME LOCALIZATION; HYPERTENSION; KIDNEY TUBULE CELL; PATHOGENESIS; REAL TIME POLYMERASE CHAIN REACTION; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

CELLS, CULTURED; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYPERTENSION; IONOMYCIN; ISOENZYMES; KIDNEY TUBULES, PROXIMAL; MEMBRANE PROTEINS; NADPH OXIDASE; ONIUM COMPOUNDS; OXIDATIVE STRESS;

EID: 84896039378     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2014.01.020     Document Type: Article

References (47)

1. Lambeth J.D. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 2004, 4:181-189.
2. Wilcox C.S. Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension?. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289:R913-935.
3. Fulton D.J. Nox5 and the regulation of cellular function. Antioxid. Redox Signal. 2009, 11:2443-2452.
4. Briones A.M., Tabet F., Callera G.E., Montezano A.C., Yogi A., He Y., Quinn M.T., Salaices M., Touyz R.M. Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR. J. Am. Soc. Hypertens 2011, 5:137-153.
5. Xue B., Beltz T.G., Johnson R.F., Guo F., Hay M., Johnson A.K. PVN adenovirus-siRNA injections silencing either NOX2 or NOX4 attenuate aldosterone/NaCl-induced hypertension in mice. Am. J. Physiol. Heart. Circ. Physiol. 2011, 302:H733-H741.
6. Shiose A., Kuroda J., Tsuruya K., Hirai M., Hirakata H., Naito S., Hattori M., Sakaki Y., Sumimoto H. A novel superoxide-producing NAD(P)H oxidase in kidney. J. Biol. Chem. 2001, 276:1417-1423.
7. Ushio-Fukai M., Zuo L., Ikeda S., Tojo T., Patrushev N.A., Alexander R.W. cAbl tyrosine kinase mediates reactive oxygen species- and caveolin-dependent AT1 receptor signaling in vascular smooth muscle: role in vascular hypertrophy. Circ. Res. 2005, 97:829-836.
8. Han W., Li H., Villar V.A., Pascua A.M., Dajani M.I., Wang X., Natarajan A., Quinn M.T., Felder R.A., Jose P.A., Yu P. Lipid rafts keep NADPH oxidase in the inactive state in human renal proximal tubule cells. Hypertension 2008, 51(part 2):481-487.
9. Guzik T.J., Chen W., Gongora M.C., Guzik B.L., Heinrich E., Lob H.E., Mangalat D., Hoch N., Dikalov S., Rudzinski P., Kapelak B., Sadowski J., Harrison D.G. Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease. J. Am. Coll. Cardiol. 2008, 52:1803-1809.
10. Sedeek M., Hebert R.L., Kennedy C.R., Burns K.D., Touyz R.M. Molecular mechanisms of hypertension: role of Nox family NADPH oxidases. Curr. Opin. Nephrol. Hypertens. 2009, 18:122-127.
11. Zeng C., Villar V.A., Yu P., Zhou L., Jose P.A. Reactive oxygen species and dopamine receptor function in essential hypertension. Clin. Exp. Hypertens. 2009, 31:156-178.
12. Maru Y., Nishino T., Kakinuma K. Expression of Nox genes in rat organs, mouse oocytes, and sea urchin eggs. DNA. Seq. 2005, 16:83-88.
13. Cheng G., Cao Z., Xu X., van Meir E.G., Lambeth J.D. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene. 2001, 269:131-140.
14. 2+-activated NADPH oxidase in testis, spleen, and lymph nodes. J. Biol. Chem. 2001, 276:37594-37601.
15. BelAiba R.S., Djordjevic T., Petry A., Diemer K., Bonello S., Banfi B., Hess J., Pogrebniak A., Bickel C., Gorlach A. NOX5 variants are functionally active in endothelial cells. Free Radic. Biol. Med. 2007, 42:446-459.
16. Montezano A.C., Burger D., Paravicini M.M., Chignalia A.Z., Yusuf H., Almasri M., He Y., Callera G.E., He G., Krause K.H., Lambeth D., Quinn M.T., Touyz R.M. Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, Rac-1-independent pathways in human endothelial cells. Circ. Res. 2010, 106:1363-1373.
17. Jay D.B., Papaharalambus C.A., Seidel-Rogol B., Dikalova A.E., Lassegue B., Griendling K.K. Nox5 mediates PDGF induced proliferation in human aortic smooth muscle cells. Free Radic. Biol. Med. 2008, 45:329-335.
18. El Jamali A., Valente A.J., Lechleiter J.D., Gamez M.J., Pearson D.W., Nauseef W.M., Clark R.A. Novel redox-dependent regulation of NOX5 by the tyrosine kinase c-Abl. Free Radic. Biol. Med. 2008, 44:868-881.
19. Jagnandan D., Church J.E., Banfi B., Stuehr D.J., Marrero M.B., Fulton D.J. Novel mechanism of activation of NADPH oxidase 5. Calcium sensitization via phosphorylation. J. Biol. Chem. 2007, 282:6494-6507.
20. Kawahara T., Lambeth J.D. Phosphatidylinositol (4,5)-bisphosphate modulates Nox5 localization via an N-terminal polybasic region. Mol. Biol. Cell. 2008, 19:4020-4031.
21. Serrander L., Jaquet V., Bedard K., Plastre O., Hartley O., Arnaudeau S., Demaurex N., Schlegel W., Krause K.H. NOX5 is expressed at the plasma membrane and generates superoxide in response to protein kinase C activation. Biochimie 2007, 89:1159-1167.
22. Tirone F., Radu L., Craescu C.T., Cox J.A. Identification of the binding site for the regulatory calcium-binding domain in the catalytic domain of NOX5. Biochemistry 2010, 49:761-771.
23. Pandey D., Patel A., Patel V., Chen F., Qian J., Wang Y., Barman S.A., Venema R.C., Stepp D.W., Rudic R.D., Fulton D.J. Expression and functional significance of NADPH oxidase 5 (Nox5) and its splice variants in human blood vessels. Am. J. Physiol. Heart Circ. Physiol. 2012, 302:H1919-H1928.
24. Zeng C., Armando I., Luo Y., Eisner G.M., Felder R.A., Jose P.A. Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice. Am. J. Physiol. Heart. Circ. Physiol. 2008, 29:H551-H569.
25. Hussain T., Lokhandwala M.F. Renal dopamine receptors and hypertension. Exp. Biol. Med. (Maywood) 2003, 228:134-142.
26. Saito I., Itsuji S., Takeshit,a E., Kawabe H., Nishino M., Winai H., Hasegawa C., Saruta T., Nagano S., Sekihara T. Increased urinary dopamine excretion in young patients with essential hypertension. Clin. Exp. Hypertens. 1994, 6:29-39.
27. O'Connell D.P., Ragsdale N.V., Boyd D.G., Felder R.A., Carey R.M. Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status. Hypertension 1997, 29:115-122.
28. 1-like receptors. Circulation 2000, 101:2302-2308.
29. Yang Z., Asico L.D., Yu P., Wang Z., Jones J.E., Escano C.S., Wang X., Quinn M.T., Sibley D.R., Romero G.G., Felder R.A., Jose P.A. D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 290:R96-R104.
30. White B.H., Sidhu A. Increased oxidative stress in renal proximal tubules of the spontaneously hypertensive rat: a mechanism for defective dopamine D1A receptor/G-protein coupling. J. Hypertens. 1998, 16:1659-1665.
31. Li H., Han W.X., Villar V.M., Keever L.B., Lu Q.S., Hopfer U., Quinn M.T., Jose P.A., Yu P.Y. D1-like receptors regulate NADPH oxidase activity and subunit expression in lipid raft microdomains of renal proximal tubule cells. Hypertension 2009, 53:1054-1061.
32. Banday A.A., Lau Y.S., Lokhandwala M.F. Oxidative stress causes renal dopamine D1 receptor dysfunction and salt-sensitive hypertension in Sprague-Dawley rats. Hypertension 2008, 51:367-375.
33. Sanada H., Jose P.A., Hazen-Martin D., Yu P.Y., Xu J., Bruns D.E., Phipps J., Carey R.M., Felder R.A. Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension 1999, 33:1036-1042.
34. Simão S., Fraga S., Jose P.A., Soares-da-Silva P. Oxidative stress and α1-adrenoceptor-mediated stimulation of the Cl-/HCO3- exchanger in immortalized SHR proximal tubular epithelial cells. Br. J. Pharmacol. 2008, 153:1445-1455.
35. Paravicini T.M., Chrissobolis S., Drummond G.R., Sobey C.G. Increased NADPH-oxidase activity and Nox4 expression during chronic hypertension is associated with enhanced cerebral vasodilatation to NADPH in vivo. Stroke 2004, 35:584-589.
36. Gildea J.J., Shah I., Weiss R., Casscells N.D., McGrath H.E., Zhang J., Felder R.A. HK-2 human renal proximal tubule cells as a model for G protein-coupled receptor kinase type 4-mediated dopamine 1 receptor uncoupling. Hypertension 2010, 56:505-511.
37. Pick E., Mizel D. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J. Immunol. Methods 1981, 46:211-226.
38. 1A receptor/Giβγ stimulates mitogen-activated protein kinase via NAD(P)H oxidase and reactive oxygen species upstream of Src in Chinese hamster ovary fibroblasts. Biochem. J. 2000, 347:61-67.
39. Simão S., Fraga S., Jose P.A., Soares-da-Silva P. Oxidative stress plays a permissive role in α2-adrenoceptor-mediated events in immortalized SHR proximal tubular epithelial cells. Mol. Cell Biochem. 2008, 315:31-39.
40. - exchanger by angiotensin II and angiotensin II type 1 receptor distribution in membrane microdomains. Hypertension 2008, 51:1332-1338.
41. Ahmarani L., Avedanian L., Al-Khoury J., Perreault C., Jacques D., Bkaily G. Whole-cell and nuclear NADPH oxidases levels and distribution in human endocardial endothelial, vascular smooth muscle, and vascular endothelial cells. Can J Physiol. Pharmacol. 2013, 91:71-79.
42. Fu X., Beer D.G., Behar J., Wands J., Lambeth D., Cao W. cAMP-response element-binding protein mediates acid induced NADPH oxidase NOX5-S expression in Barrett esophageal adenocarcinoma cells. J. Biol. Chem. 2006, 281:20368-20382.
43. Lassègue B., Griendling K.K. Reactive oxygen species in hypertension. Am. J. Hypertens. 2004, 17:852-860.
44. Ushio-Fukai M. Localizing NADPH oxidase-derived ROS. Sci. STKE 2006, 349:re8.
45. Brar S.S., Corbin Z., Kennedy T.P., Hemendinger R., Thornton L., Bommarius B., Arnold R.S., Whorton A.R., Sturrock A.B., Huecksteadt T.P., Quinn M.T., Krenitsky K., Ardie K.G., Lambeth J.D., Hoidal J.R. NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells. Am. J. Physiol. Cell Physiol. 2003, 285:C353-C369.
46. Trivedi M., Lokhandwala M.F. Rosiglitazone restores renal D1A receptor-Gs protein coupling by reducing receptor hyperphosphorylation in obese rats. Am. J. Physiol. Renal. Physiol. 2005, 289:F298-304.
47. Yu P., Asico L.D., Luo Y., Andrews P., Eisner G.,M., Hopfer U., Felder R.A., Jose P.A. D1 dopamine receptor hyperphosphorylation in renal proximal tubules in hypertension. Kidney. Int. 2006, 70:1072-1079.